Provention Bio (PRVB) Announces $125 Million Term Loan Facility with Hercules Capital
Don't think we've ever seen anything like this before. Most investors who prefer to invest post FDA approval, invest post FDA approval....
OnFolio Holdings Inc. (ONFO) Announces Pricing of $13.7 Million Initial Public Offering and Nasdaq...
Nice work by EF Hutton. We like this business model. Similar to old school incubator, but they acquire rather than invest and...
Revive Therapeutics (RVVTF) Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life...
VERU Inc. (VERU) $24. High Risk, Minimal Reward?
Pre-FDA Approval Play. The Shares Are Now in the Hands of Fast Money Traders.
You Can't Kiss all the...
Adding Alkaline Water (WTER) to 2022 Beverage Watch List at $0.46, More Names Coming.
The Alkaline Water Company (WTER). Identifies $15 Million in Cost Savings and Margin Enhancements.
With nearly $200 million...
What is NAC (N-Acetyl-L-Cysteine)? (Dr Eric Berg)
https://youtu.be/oPdGOrqTfhA
What is NAC good for? (and How Much to Take?)
Chula Vista Scamster Gets Pinched
Great detective work by the SEC on this. If you ever wonder how/why your stock or stock you're following drops from $1.00...
Revive Therapeutics (RVVTF) Enters the Danger Zone.
What Danger You Ask?
Danger #1, the FDA doesn't like the data, and you own the stock.
Adding Provention Bio (PRVB) $4.60 to 2022 Biotech Watch List.
This is in our 'Stocks we Hope to Double' Watch List.
LIVE QUOTE
AI and Machine Learning Start-Up Nowigence (NWGO) Announces Deal With EquiPPP Technologies (NSE: EQIPPP).
Nowigence CEO Anoop Bhatia was voted most innovative AI NLP Company CEO 2020.With over two decades in various GE companies across different...